Mutagenicity and carcinogenicity in relation to DNA adduct formation in rats fed leucomalachite green

Culp, 1996, Malachite green: a toxicological review, J. Am. Coll. Toxicol., 15, 219, 10.3109/10915819609008715 Veterinary Medicines Directorate, Annual Report on Surveillance for Veterinary Residues in 1995, Ministry of Agriculture, Fisheries and Food, UK, PB 2756, July 1996. Doerge, 1998, Analysis of malachite green and metabolites in fish using liquid chromatography atmospheric pressure chemical ionization mass spectrometry, Rapid Commun. Mass Spectrom., 12, 1625, 10.1002/(SICI)1097-0231(19981115)12:21<1625::AID-RCM373>3.0.CO;2-I NIOSH, Unpublished provisional data as of 7/1/1990, NIOSH NOE (1981–1983) Cincinnati, OH, US. DHHS, PHS, CDC, National Institute for Occupational Safety and Health, 1990. Fernandes, 1991, Enhancing effect of malachite green on the development of hepatic pre-neoplastic lesions induced by N-nitrosodiethylamine in rats, Carcinogenesis, 12, 839, 10.1093/carcin/12.5.839 IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man: Some aromatic amines and related nitro compounds—hair dyes, colouring agents and miscellaneous industrial chemicals, Vol. 16, IARC, Lyon, 1978, pp. 153–220. N.A. Littlefield, Chronic toxicity and carcinogenicity studies of gentian violet in Fischer 344 rats, NCTR technical report for experiment no. 338, National Center for Toxicological Research, Jefferson, AR 72079, 1988. Culp, 1999, Toxicity and metabolism of malachite green and leucomalachite green during short-term feeding to Fischer 344 rats and B6C3F1 mice, Chem. Biol. Interact., 122, 153, 10.1016/S0009-2797(99)00119-2 Fessard, 1999, Mutagenicity of malachite green and leucomalachite green in in vitro tests, J. Appl. Toxicol., 19, 421, 10.1002/(SICI)1099-1263(199911/12)19:6<421::AID-JAT595>3.0.CO;2-6 Dycaico, 1994, The use of shuttle vectors for mutation analysis in transgenic mice and rats, Mutat. Res., 307, 461, 10.1016/0027-5107(94)90257-7 Cosentino, 1999, Effects of extended chronic exposures on endogenous and transgenic loci: implications for low-dose extrapolations, Environ. Mol. Mutagen., 34, 208, 10.1002/(SICI)1098-2280(1999)34:2/3<208::AID-EM21>3.0.CO;2-1 Manjanatha, 2000, DNA adduct formation and molecular analysis of in vivo lacI mutations in the mammary tissue of Big Blue® rats treated with 7,12-dimethylbenz[a]anthracene, Carcinogenesis, 21, 265, 10.1093/carcin/21.2.265 Culp, 1994, Comparison of DNA adduct formation in mice fed coal tar or benzo[a]pyrene, Carcinogenesis, 15, 247, 10.1093/carcin/15.2.247 Gupta, 1985, Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen: DNA adducts, Cancer Res., 45, 5656 Wright, 1992, Adjusted P values for simultaneous inference, Biometrics, 48, 1005, 10.2307/2532694 F.A. Beland, F.F. Kadlubar, Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons, In: C.S. Cooper, P.L. Grover (Eds.), Handbook of Experimental Pharmacology, Vol. 94, Part I, Springer, Berlin, 1990, pp. 267–325. Hayward, 1995, Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene, Carcinogenesis, 16, 2429, 10.1093/carcin/16.10.2429 Leavitt, 1997, Assessment of the mutagenicity of dichloroacetic acid in lacI transgenic B6C3F1 mouse liver, Carcinogenesis, 18, 2101, 10.1093/carcin/18.11.2101 Shane, 1999, Oxazepam is mutagenic in vivo in Big Blue® transgenic mice, Carcinogenesis, 20, 1315, 10.1093/carcin/20.7.1315 Beland, 1999, Hprt lymphocyte mutant frequency in relation to DNA adduct formation in rats fed the hepatocarcinogen 2-acetylaminofluorene, Cancer Lett., 143, 249, 10.1016/S0304-3835(99)00134-2 Manjanatha, 1998, Comparison of in vivo mutagenesis in the endogenous Hprt gene and the lacI transgene of Big Blue® rats treated with 7,12-dimethylbenz[a]anthracene, Mutat. Res., 401, 165, 10.1016/S0027-5107(98)00006-2 Tao, 1993, Comparison of somatic mutation in a transgenetic versus host locus, Proc. Natl. Acad. Sci. U.S.A., 90, 10681, 10.1073/pnas.90.22.10681 Gupta, 1988, 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures, Carcinogenesis, 9, 1687, 10.1093/carcin/9.9.1687